Investor List:

Top Medical Devices Series A Investors in Canada (14)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Series B), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Robotics (Pre-seed), Investors in Hardware (Pre-seed), Investors in Digital Health (Seed), Investors in Diagnostics (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Drug Delivery (Series B), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Series B), Investors in Pharmaceuticals (Series A), Investors in Robotics (Series B), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Hardware (Series A), Investors in Digital Health (Series B), Investors in Robotics (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Canada (Other Lists), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Kunal Sethi, General Partner at Prithvi Ventures
Kunal Sethi
Prithvi Ventures·General Partner
Sweet spot: $1M
Range: $400K - $9.5M
Investors in Singapore, Investors in United Kingdom, Investors in Melbourne (Australia), Investors in Canada, Investors in United States, Investors in Europe
Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Chemicals (Seed), Investors in Drug Delivery (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Drug Delivery (Seed), Investors in Medical Devices (Seed), Investors in Chemicals (Series A), Investors in Chemicals (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in Drug Delivery (Series A), Investors in AgTech (Seed), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Series A), Investors in AgTech (Series A), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
Photo of Eric Rosenblum, Managing Partner at Foothill Ventures (formerly Tsingyuan Ventures)
Eric Rosenblum
Sweet spot: $1M
Range: $100K - $10.0M
Investors in United States, Investors in Canada
Investors in Material Science (Series A), Investors in Medical Devices (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Manufacturing (Series A), Investors in Manufacturing (Pre-seed), Investors in Developer Tools (Pre-seed), Investors in Logistics (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in EnergyTech (Series A), Investors in Developer Tools (Series A), Investors in Logistics (Series A), Investors in Health IT (Series A), Investors in EnergyTech (Seed), Investors in Manufacturing (Seed), Investors in Logistics (Seed), Investors in Health IT (Pre-seed), Investors in Developer Tools (Seed), Investors in Health IT (Seed), Investors in AI (Pre-seed), Investors in Enterprise (Series A), Investors in Medical Devices (Pre-seed), Investors in Enterprise (Pre-seed), Investors in AI (Series A), Investors in SaaS (Series A), Investors in SaaS (Pre-seed), Investors in Material Science (Pre-seed), Investors in Enterprise (Seed), Investors in Material Science (Series A), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Material Science (Seed), Investors in Manufacturing (Pre-seed), Investors in Medical Devices (Series A), Investors in Manufacturing (Series A), Investors in Medical Devices (Seed), Investors in EnergyTech (Pre-seed), Investors in Logistics (Pre-seed), Investors in Manufacturing (Seed), Investors in Logistics (Series A), Investors in Developer Tools (Pre-seed), Investors in Canada (Other Lists), Investors in EnergyTech (Series A), Investors in EnergyTech (Seed), Investors in Logistics (Seed), Investors in Health IT (Pre-seed), Investors in Developer Tools (Series A), Investors in Developer Tools (Seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Health IT (Series A), Investors in SaaS (Pre-seed), Investors in Health IT (Seed), Investors in Investors who were founders (Other Lists), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in SaaS (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in AI (Seed), Investors in Enterprise (Series A), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Geron Vanderfeesten, Managing Director at VDF Ventures
Geron Vanderfeesten
VDF Ventures·Managing Director
Sweet spot: $2.0M
Range: $500K - $15.0M
Investors in Middle East, Investors in Europe, Investors in Canada, Investors in United States
Investors in Payments (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Payments (Series A), Investors in Medical Devices (Series A), Investors in AgTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Payments (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Web3/Blockchain (Series B), Investors in AgTech (Series A), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in Web3/Blockchain (Series A), Investors in AI (Series B), Investors in SaaS (Series B), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Medical Devices (Series B), Investors in FinTech (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in AgTech (Series B), Investors in Medical Devices (Series A), Investors in Payments (Series B), Investors in Cybersecurity (Series B), Investors in Medical Devices (Seed), Investors in AgTech (Series A), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Web3/Blockchain (Series B), Investors in Payments (Series A), Investors in AgTech (Seed), Investors in Canada (Other Lists), Investors in Payments (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in Web3/Blockchain (Series A), Investors in AI (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Web3/Blockchain (Seed), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in AI (Series A), Investors in SaaS (Series A), Investors in AI (Seed), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in SaaS (Seed), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Enterprise (Seed), Investors in FinTech (Seed)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in Chemicals (Series A), Investors in Semiconductors (Series A), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series A), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Chemicals (Series A), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in AI (Series A), Investors in Medical Devices (Series B), Investors in Material Science (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series B), Investors in Canada (Other Lists), Investors in AI (Series A), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Jean-François Pariseau, Partner at Amplitude VC
Jean-François Pariseau
Amplitude VC·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada, Investors in Montreal
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Impact (Series A), Investors in Digital Health (Seed), Investors in Impact (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in AI (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Impact (Series A), Investors in Canada (Other Lists), Investors in Impact (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in AI (Seed)
Photo of Alexandre Nossovskoi, Principal at Esplanade HealthTech Ventures
Alexandre Nossovskoi
Sweet spot: $1.5M
Range: $500K - $5.0M
Investors in Canada, Investors in United States
Investors in Wellness & Fitness (Pre-seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Enterprise Infrastructure (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Seed), Investors in Digital Health (Series A), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Consumer Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Enterprise Infrastructure (Series A), Investors in Consumer Health (Seed), Investors in Analytics (Series A), Investors in Enterprise Infrastructure (Seed), Investors in SMB Software (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Analytics (Pre-seed), Investors in Health IT (Series A), Investors in SMB Software (Pre-seed), Investors in SMB Software (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Pre-seed), Investors in Canada (Other Lists), Investors in Analytics (Seed), Investors in British Columbia (Other Lists), Investors in Health IT (Seed), Investors in AI (Pre-seed), Investors in AI (Series A), Investors in Wellness & Fitness (Pre-seed), Investors in AI (Seed), Investors in Enterprise Infrastructure (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Investors who were founders (Other Lists), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Enterprise Infrastructure (Series A), Investors in Digital Health (Pre-seed), Investors in SMB Software (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Analytics (Pre-seed), Investors in Enterprise Infrastructure (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in SMB Software (Series A), Investors in Analytics (Series A), Investors in Consumer Health (Series A), Investors in SMB Software (Seed), Investors in Analytics (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in AI (Series A), Investors in AI (Seed)
Photo of Jason Robertson, General Partner at Nimbus Synergies
Jason Robertson
Nimbus Synergies·General Partner
Sweet spot: $1M
Range: $500K - $1.5M
Investors in Canada, Investors in British Columbia
Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Series A), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Health IT (Pre-seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Wellness & Fitness (Series A), Investors in British Columbia (Other Lists), Investors in Canada (Other Lists), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Medical Devices (Series A), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Investors who were founders (Other Lists), Investors in Digital Health (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Health IT (Series A)